By Deron Hamel Epilepsy Ontario’s weekly column, the Voices of Epilepsy, saw strong readership in 2015, and of all the issues covered this year one received more buzz on the organization’s social-media platforms than any other: cannabidiol (CBD). CBD is a substance derived from the marijuana plant. It is the most abundant, non-psychoactive chemical compound…
By Deron Hamel Summerfest Camp is going into its 22nd year in 2016 and families can register their children for a session in this unique, two-week camping experience starting Dec. 4. Each year Summerfest Camp, which is sponsored by Epilepsy Ontario, has an average of 20 to 40 children and youths who have epilepsy attend…
By Deron Hamel When people share their stories about living with epilepsy it often inspires others to do the same. This not only helps build a stronger community among those living with epilepsy, but many of these stories also provide hope to those living with seizure disorders. Steve Rutledge contacted Epilepsy Ontario in February to…
By Deron Hamel A 2,000-per-cent price hike on a medication to treat infantile spasms is “predatory behaviour” on the part of Questcor Pharmaceuticals, and drug companies could hike prices on other seizure medications if policies aren’t put into place, says pediatric neurologist Dr. Carter Snead. Infantile spasms – also called West syndrome – is a…
Sponsor Image 1
Sponsor Image 3
Sponsor Image 1
Sponsor Image 2
Sponsor Image 3
